This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Bos taurus
Homo sapiens
Mus musculus
Rattus norvegicus
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Adipocyte (3T3-L1)
B cell (Raji)
Blood
Bone marrow stromal cells
Breast cancer cells (MDA-MB-231)
Caput epithelial cell
Caput luminal fluid
Cauda epithelial cell
Cauda luminal fluid
Colorectal cancer cell (SW480)
Colorectal cancer cell (SW620)
Drug-resistant acute lymphoblastic leukemia cell (CCRF-CEM MDR variant VLB100)
Drug-resistant breast adenocarcinoma cell (MCF-7 MDR variant MCF-7/DX)
Embryonic kidney cell (HEK293T)
Fetal human colon epithelial cell (FHC)
Immature bone marrow-derived dendritic cell
Liver cancer cells (CSQT-2)
Liver cancer cells (HCC-LM3)
Liver cancer cells (HepG2)
Liver cancer cells (MHCC-97L)
Lung cancer cell (DMS563)
Lung cancer cell (NCI_H69)
Lung cancer cell (SBC-3)
Lung cancer cells (A549)
Malignant melanoma cell (A375)
Mammary gland cells (MCF10A)
Mammary gland cells (NMuMG)
Mature bone marrow-derived dendritic cell
Metastatic gastric cacncer cell (AZP7a)
Metastatic gastric cancer cell (AZ521)
Oral cancer cells (HOC313-LM)
Oral cancer cells (HOC313-P)
Pancreatic cancer cells (KPC)
Pancreatic ductal epithelial cells (MPDC)
Plasma
Seminal plasma
Serum
T cell (Jurkat)
By sample status
24 hr culture
72 hr culture
Cisplatin-resistant
Day 2-4 after differentiation into adipocytes
Day 8-10 after differentiation into adipocytes
Extremely severe hand, foot, and mouth disease
Healthy_timepoint1
Healthy_timepoint2
Multiple myeloma patients
Normal
Normal_Agilent
Normal_Exiqon
Reflux esophagitis
Sample A_Biooscientific
Sample A_Illumina
Sample A_NEB
Sample B_Biooscientific
Sample B_NEB
Sample C_NEB
Transplant islets into mouse xenotransplantation-rejected
Type 1 diabetes
Vasectomy
Vasovasostomy
miR-146a-treated
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-152-3p
MIMAT0000438
0.0e+0
2.8e-1
MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148b-3p
MIMAT0000759
3.5e-6
4.8e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148a-3p
MIMAT0000243
0.0e+0
4.4e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148b-3p
MIMAT0000759
0.0e+0
5.0e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148a-3p
MIMAT0000243
0.0e+0
1.1e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148a-3p
MIMAT0000243
0.0e+0
6.8e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148a-3p
MIMAT0000243
0.0e+0
1.3e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000056_2
57
/
0
/
57
mmu-miR-148b-3p
MIMAT0000580
0.0e+0
4.0e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148a-3p
MIMAT0000243
0.0e+0
2.3e-1
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000056_2
57
/
0
/
57
hsa-miR-152-3p
MIMAT0000438
0.0e+0
5.0e-1
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148a-3p
MIMAT0000243
0.0e+0
1.7e-1
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000056_2
57
/
0
/
57
hsa-miR-152-3p
MIMAT0000438
0.0e+0
3.6e-1
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148a-3p
MIMAT0000243
1.0e-3
1.0e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148b-3p
MIMAT0000759
1.0e-3
1.0e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000056_2
57
/
0
/
57
mml-miR-148b-3p
MIMAT0006209
1.0e-3
1.0e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000056_2
57
/
0
/
57
mmu-miR-148b-3p
MIMAT0000580
1.0e-3
1.0e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148b-3p
MIMAT0000759
0.0e+0
4.3e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148b-3p
MIMAT0000759
0.0e+0
4.9e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000056_2
57
/
0
/
57
mmu-miR-152-3p
MIMAT0000162
0.0e+0
3.0e-2
Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.
MIPF0000056_2
57
/
0
/
57
mmu-miR-148a-3p
MIMAT0000516
0.0e+0
1.6e-4
Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.
MIPF0000056_2
57
/
0
/
57
mmu-miR-148b-3p
MIMAT0000580
0.0e+0
1.0e-1
Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.
MIPF0000056_2
57
/
0
/
57
mmu-miR-152-3p
MIMAT0000162
0.0e+0
3.2e-1
Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148b-3p
MIMAT0000759
5.4e-3
4.6e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148b-3p
MIMAT0000759
1.5e-4
4.1e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000056_2
57
/
0
/
57
rno-miR-152-3p
MIMAT0000854
0.0e+0
4.9e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000056_2
57
/
0
/
57
rno-miR-152-3p
MIMAT0000854
0.0e+0
4.9e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000056_2
57
/
0
/
57
rno-miR-152-3p
MIMAT0000854
0.0e+0
4.9e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000056_2
57
/
0
/
57
rno-miR-152-3p
MIMAT0000854
0.0e+0
5.0e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000056_2
57
/
0
/
57
rno-miR-152-3p
MIMAT0000854
0.0e+0
5.0e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000056_2
57
/
0
/
57
rno-miR-152-3p
MIMAT0000854
0.0e+0
5.0e-1
Expression of Serum Exosomal and Esophageal MicroRNA in Rat Reflux Esophagitis.
Int J Mol Sci. 2017 Jul 25;18(8). pii: E1611. doi: 10.3390/ijms18081611.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148b-3p
MIMAT0000759
1.8e-2
1.8e-2
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148a-3p
MIMAT0000243
0.0e+0
1.4e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148b-3p
MIMAT0000759
0.0e+0
1.3e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148a-3p
MIMAT0000243
0.0e+0
3.4e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148b-3p
MIMAT0000759
0.0e+0
3.5e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148b-3p
MIMAT0000759
2.8e-2
2.8e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000056_2
57
/
0
/
57
hsa-miR-148b-3p
MIMAT0000759
2.5e-2
2.5e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000056_2
57
/
0
/
57
<
[3]